686 related articles for article (PubMed ID: 15119632)
41. Effects of new peritoneal dialysis solutions, pyridoxamine and AT1 receptor blocker, on TGF-beta1 and VEGF expression in rat peritoneal mesothelial cells.
Mizuiri S; Ohashi Y; Hemmi H; Arita M; Yamada K; Aoki T; Miyagi M; Sakai K; Aikawa A
Am J Nephrol; 2009; 30(3):295-302. PubMed ID: 19546527
[TBL] [Abstract][Full Text] [Related]
42. Selected growth factors in peritoneal dialysis: their relationship to markers of inflammation, dialysis adequacy, residual renal function, and peritoneal membrane transport.
Stompór T; Zdzienicka A; Motyka M; Dembińska-Kieć A; Davies SJ; Sulowicz W
Perit Dial Int; 2002; 22(6):670-6. PubMed ID: 12556068
[TBL] [Abstract][Full Text] [Related]
43. Effect of valsartan versus lisinopril on peritoneal sclerosis in rats.
Duman S; Sen S; Duman C; Oreopoulos DG
Int J Artif Organs; 2005 Feb; 28(2):156-63. PubMed ID: 15770604
[TBL] [Abstract][Full Text] [Related]
44. L-2-oxothiazolidine-4-carboxylate: an agent that modulates lipopolysaccharide-induced peritonitis in rats.
Korybalska K; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Moberly J; Martis L; Breborowicz A; Oreopoulos DG
Perit Dial Int; 2002; 22(3):293-300. PubMed ID: 12227385
[TBL] [Abstract][Full Text] [Related]
45. Effects of low-glucose degradation product solution on peritoneal membrane characteristics in peritoneal dialysis patients: a 3-year follow-up study.
Park JW; Kang SH; Do JY
Iran J Kidney Dis; 2014 Jan; 8(1):58-64. PubMed ID: 24413723
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
Rodrigues AS; Martins M; Korevaar JC; Silva S; Oliveira JC; Cabrita A; Castro e Melo J; Krediet RT
Am J Nephrol; 2007; 27(1):84-91. PubMed ID: 17284895
[TBL] [Abstract][Full Text] [Related]
47. Reduction of perlecan synthesis and induction of TGF-beta1 in human peritoneal mesothelial cells due to high dialysate glucose concentration: implication in peritoneal dialysis.
Yung S; Chen XR; Tsang RC; Zhang Q; Chan TM
J Am Soc Nephrol; 2004 May; 15(5):1178-88. PubMed ID: 15100358
[TBL] [Abstract][Full Text] [Related]
48. Hyperbranched polyglycerol is superior to glucose for long-term preservation of peritoneal membrane in a rat model of chronic peritoneal dialysis.
Du C; Mendelson AA; Guan Q; Dairi G; Chafeeva I; da Roza G; Kizhakkedathu JN
J Transl Med; 2016 Dec; 14(1):338. PubMed ID: 27964722
[TBL] [Abstract][Full Text] [Related]
49. Glucose degradation products in peritoneal dialysis solution impair angiogenesis by dysregulating angiogenetic factors in endothelial and vascular smooth muscle cells.
Aihara S; Nakano T; Torisu K; Kitazono T
Clin Exp Nephrol; 2022 Dec; 26(12):1160-1169. PubMed ID: 36070106
[TBL] [Abstract][Full Text] [Related]
50. Effect of peritonitis on peritoneal transport characteristics: glucose solution versus polyglucose solution.
Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
Kidney Int; 2000 Apr; 57(4):1704-12. PubMed ID: 10760106
[TBL] [Abstract][Full Text] [Related]
51. Does the biocompatibility of the peritoneal dialysis solution matter in assessment of peritoneal function?
Parikova A; Struijk DG; Zweers MM; Langedijk M; Schouten N; van den Berg N; Duis S; Krediet RT
Perit Dial Int; 2007; 27(6):691-6. PubMed ID: 17984433
[TBL] [Abstract][Full Text] [Related]
52. Functional and structural alterations of peritoneum and secretion of fibrotic cytokines in rats caused by high glucose peritoneal dialysis solutions.
Liu Y; Li JF; Liu H; Liu FY; Peng YM; Liu YH; Cheng MC; Chen GC; Zhou X
Ren Fail; 2014 Mar; 36(2):292-9. PubMed ID: 24152223
[TBL] [Abstract][Full Text] [Related]
53. The effects of ouabain and potassium on peritoneal fluid and solute transport characteristics.
Park MS; Lee EY; Lee NS; Waniewski J; Lindholm B; Lee HB
Perit Dial Int; 1998; 18(4):402-9. PubMed ID: 10505562
[TBL] [Abstract][Full Text] [Related]
54. The effect of dialysate acidity on peritoneal solute transport in the rat.
Park MS; Heimbürger O; Waniewski J; Werynski A; Lee HB; Bergström J; Lindholm B
Perit Dial Int; 1995; 15(8):312-9. PubMed ID: 8785228
[TBL] [Abstract][Full Text] [Related]
55. Pyridoxal phosphate and hepatocyte growth factor prevent dialysate-induced peritoneal damage.
Nakamura S; Niwa T
J Am Soc Nephrol; 2005 Jan; 16(1):144-50. PubMed ID: 15563557
[TBL] [Abstract][Full Text] [Related]
56. Glucose and mannitol have different effects on peritoneal morphology in chronically dialyzed rats.
Styszynski A; Kwiatkowska B; Wieczorowska-Tobis K; Breborowicz A; Oreopoulos DG
Adv Perit Dial; 2003; 19():15-9. PubMed ID: 14763027
[TBL] [Abstract][Full Text] [Related]
57. Peritoneal equilibration test with conventional 'low pH/high glucose degradation product' or with biocompatible 'normal pH/low glucose degradation product' dialysates: does it matter?
Van Overmeire L; Goffin E; Krzesinski JM; Saint-Remy A; Bovy P; Cornet G; Bovy C
Nephrol Dial Transplant; 2013 Jul; 28(7):1946-51. PubMed ID: 23223220
[TBL] [Abstract][Full Text] [Related]
58. The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial.
Choi HY; Kim DK; Lee TH; Moon SJ; Han SH; Lee JE; Kim BS; Park HC; Choi KH; Ha SK; Han DS; Lee HY
Perit Dial Int; 2008; 28(2):174-82. PubMed ID: 18332454
[TBL] [Abstract][Full Text] [Related]
59. Update on mechanisms of ultrafiltration failure.
Kim YL
Perit Dial Int; 2009 Feb; 29 Suppl 2():S123-7. PubMed ID: 19270200
[TBL] [Abstract][Full Text] [Related]
60. Physiological saline is not a biocompatible peritoneal dialysis solution.
Wang T; Heimbürger O; Qureshi AR; Waniewski J; Bergström J; Lindholm B
Int J Artif Organs; 1999 Feb; 22(2):88-93. PubMed ID: 10212043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
